Gender-dependent miR-375 promoter methylation and the risk of type 2 diabetes

Experimental and Therapeutic Medicine

Volumn 5, Issue 6, 2013, Pages 1687-1692

  Cheng, Jia ^a,b   Wang, Lingyan ^c   Xu, Leiting ^a   Wang, Hongwei ^d   Liu, Panpan ^a   Bu, Shizhong ^a   Ye, Meng ^a   Zhang, Lina ^a   Wang, Qinwen ^a   Duan, Shiwei ^a  

^a NINGBO UNIVERSITY   (China)

^b Ningbo Kangning Hospital   (China)

^c NINGBO NO 2 HOSPITAL   (China)

^d UNIVERSITY OF CHICAGO   (United States)

Author keywords

DNA methylation; miR 375; Promoter; Type 2 diabetes

Indexed keywords

ALANINE AMINOTRANSFERASE; CHOLESTEROL; CPG1 DINUCLEOTIDE; CPG2 DINUCLEOTIDE; CPG3 DINUCLEOTIDE; CPG4 DINUCLEOTIDE; CPG5 DINUCLEOTIDE; CPG6 DINUCLEOTIDE; CPG7 DINUCLEOTIDE; CPG8 DINUCLEOTIDE; DINUCLEOTIDE; GLUCOSE; MICRORNA 375; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; URIC ACID;

ADULT; AGED; ARTICLE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CPG ISLAND; DNA METHYLATION; FEMALE; GENDER; HUMAN; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PHENOTYPE; PROMOTER REGION; PYROSEQUENCING; RISK;

EID: 84876544330     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2013.1069     Document Type: Article

References (24)

1. Shantikumar S, Caporali A and Emanueli C: Role of microRNAs in diabetes and its cardiovascular complications. Cardiovasc Res 93: 583-593, 2012.
2. Shaw JE, Sicree RA and Zimmet PZ: Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract 87: 4-14, 2010.
3. Wild S, Roglic G, Green A, et al: Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27: 1047-1053, 2004.
4. Fernandez-Valverde SL, Taft RJ and Mattick JS: MicroRNAs in β-cell biology, insulin resistance, diabetes and its complications. Diabetes 60: 1825-1831, 2011.
5. Lee RC, Feinbaum RL and Ambros V: The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 75: 843-854, 1993.
6. Wightman B, Ha I and Ruvkun G: Posttranscriptional regulation of the heterochronic gene lin-14 by lin-4 mediates temporal pattern formation in C. elegans. Cell 75: 855-862, 1993.
7. Dehwah MA, Xu A and Huang Q: MicroRNAs and type 2 diabetes/obesity. J Genet Genomics 39: 11-18, 2012.
8. Avnit-Sagi T, Kantorovich L, Kredo-Russo S, et al: The promoter of the pri-miR-375 gene directs expression selectively to the endocrine pancreas. PLoS One 4: e5033, 2009.
9. Krutzfeldt J and Stoffel M: MicroRNAs: a new class of regulatory genes affecting metabolism. Cell Metab 4: 9-12, 2006.
10. Poy MN, Hausser J, Trajkovski M, et al: miR-375 maintains normal pancreatic alpha-and beta-cell mass. Proc Natl Acad Sci USA 106: 5813-5818, 2009.
11. Kong L, Zhu J, Han W, et al: Significance of serum microRNAs in pre-diabetes and newly diagnosed type 2 diabetes: a clinical study. Acta Diabetol 48: 61-69, 2011.
12. Barres R and Zierath JR: DNA methylation in metabolic disorders. Am J Clin Nutr 93: 897S-900S, 2011.
13. Volkmar M, Dedeurwaerder S, Cunha DA, et al: DNA methylation profiling identifies epigenetic dysregulation in pancreatic islets from type 2 diabetic patients. EMBO J 31: 1405-1426, 2012.
14. Toperoff G, Aran D, Kark JD, et al: Genome-wide survey reveals predisposing diabetes type 2-related DNA methylation variations in human peripheral blood. Hum Mol Genet 21: 371-383, 2012.
15. Baroukh NN and Van Obberghen E: Function of microRNA-375 and microRNA-124a in pancreas and brain. FEBS J 276: 6509-6521, 2009.
16. World Health Organization. Definition, Diagnosis and Classification of Diabetes mellitus and its Complications; Part 1: Diagnosis and Classification of Diabetes Mellitus. Department of Noncommunicable Disease Surveillance, Geneva, 1999.
17. Bredfeldt TG, Greathouse KL, Safe SH, et al: Xenoestrogen-induced regulation of EZH2 and histone methylation via estrogen receptor signaling to PI3K/AKT. Mol Endocrinol 24: 993-1006, 2010.
18. Li L, Lee KM, Han W, et al: Estrogen and progesterone receptor status affect genome-wide DNA methylation profile in breast cancer. Hum Mol Genet 19: 4273-4277, 2010.
19. Starlard-Davenport A, Tryndyak VP, James SR, et al: Mechanisms of epigenetic silencing of the Rassf1a gene during estrogen-induced breast carcinogenesis in ACI rats. Carcinogenesis 31: 376-381, 2010.
20. Poy MN, Eliasson L, Krutzfeldt J, et al: A pancreatic islet-specific microRNA regulates insulin secretion. Nature 432: 226-230, 2004.
21. Ling HY, Wen GB, Feng SD, et al: MicroRNA-375 promotes 3T3-L1 adipocyte differentiation through modulation of extracellular signal-regulated kinase signalling. Clin Exp Pharmacol Physiol 38: 239-246, 2011.
22. Husseiny MI, Kuroda A, Kaye AN, et al: Development of a quantitative methylation-specific polymerase chain reaction method for monitoring beta cell death in type 1 diabetes. PLoS One 7: e47942, 2012.
23. Kuroda A, Rauch TA, Todorov I, et al: Insulin gene expression is regulated by DNA methylation. PLoS One 4: e6953, 2009.
24. Ekstrom TJ, Lavebratt C and Schalling M: The importance of epigenomic studies in schizophrenia. Epigenomics 4: 359-362, 2012.